# Korean Biotech Company K-Medichem Expands Global Market Reach with PDRN Derma Skincare Line in Vietnam, Indonesia and Beyond

- Link: https://www.thailand-business-news.com/pr-news/korean-biotech-company-k-medichem-expands-global-market-reach-with-pdrn-derma-skincare-line-in-vietnam-indonesia-and-beyond
- Published: 2026-09-08T09:50:00+07:00
- Author: PR Newswire

◦ PDRN Derma cream, serum, and mask lineup positions premium K-dermocosmetics based
   on patented ingredients for Southeast Asian market expansion

CHUNCHEON, South Korea, Sept. 8, 2026 /PRNewswire/ — K-Medichem Co., Ltd. (K-Medichem),
a Korean biotech company built on university research, is accelerating its sales
expansion across Vietnam, Indonesia, and other global markets with the PDRN skincare
range from its premium brand, DAYNICS. With interest in skin-barrier and sensitive
skin care surging across Southeast Asia, K-Medichem aims to strengthen its global
strategy by delivering science-based, functional K-dermocosmetics that prioritize
efficacy and safety.

 [](https://mmx.prnasia.com/media/MS1983141/20260907221153EDT_image_1.jpg?id=OA2934305&p=medium600)

K-Medichem’s premium derma skincare brand DAYNICS’ PDRN-Madeca Derma Cream, formulated
with plant-derived PDRN, madecassoside, and K-Medichem’s proprietary patented ingredient
NCT.

Developed through advanced biomaterial technology and university R&D, DAYNICS is
dedicated to restoring the skin’s inherent health. Moving beyond basic moisturization,
the brand offers a multifunctional derma-care solution designed to support skin 
barrier care, renewal, conditioning, soothing, and antioxidant protection.

The flagship product, **DAYNICS PDRN-****Madeca** **Derma Cream**, features plant-
derived polydeoxyribonucleotide (PDRN), madecassoside, and N-Caffeoyl Tyramine (
NCT)—a patented ingredient independently developed by K-Medichem. Plant-derived 
PDRN supports skin regeneration, tissue recovery, and barrier reinforcement. Madecassoside,
derived from _Centella asiatica_, helps soothe skin sensitized by external stimuli.
Furthermore, K-Medichem’s proprietary NCT protects the skin from oxidative stress
caused by UV exposure and fine dust through powerful antioxidant activity. These
three key ingredients work synergistically in a skin-friendly formulation to provide
intensive moisturization, soothing care, and skin-renewal support.

Complementing the cream, K-Medichem has launched the **DAYNICS PDRN-Madeca Derma
Serum** and **DAYNICS PDRN-Madeca Derma Serum Mask** to complete its premium skincare
lineup. The serum delivers concentrated active ingredients for intensive nourishment,
while the mask serves as an intensive-care treatment for targeted hydration and 
barrier recovery. Together, these products form a comprehensive daily skincare routine.

As an R&D-focused enterprise, K-Medichem continually commercializes university research
outcomes into differentiated dermocosmetics. Building on this expertise, the company
plans to steadily expand its distribution network across Southeast Asia and into
broader global markets.

DAYNICS is a premium bio-derma skincare brand developed on the basis of advanced
technology and patented functional ingredients, said a K-Medichem representative.
K-Medichem will continue to expand their PDRN Derma lineup, strengthen cooperation
with local distribution partners, and grow DAYNICS into a trusted K-derma brand 
globally.

1. Official Website

[http://www.skinmedichem.co.kr/](http://www.skinmedichem.co.kr/)

2. Instagram

[https://www.instagram.com/kmedichem](https://www.instagram.com/kmedichem)

3. YouTube

[https://www.youtube.com/@Kmedichem](https://www.youtube.com/@Kmedichem)

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Korean Biotech Company K-Medichem Expands Global Market Reach with PDRN Derma Skincare Line in Vietnam, Indonesia and Beyond ](http://www.prnasia.com/story/archive/5042143_AE42143_0?rand=184833)